tuberculosis

Tuberculosis: A Persistent Threat to Global Health - Part 4: Targeting M. tuberculosis Carbon Metabolism In Vivo (26:12)

submitted by: video_collector
All pathogens must acquire and assimilate nutrients from their hosts in order to grow and multiply -- our tissues are literally their food -- yet surprisingly little is known about this fundamental aspect of the pathogenic lifestyle. Accumulating evidence suggests that M. tuberculosis might utilize fatty acids as its principal carbon and energy source during infection. The fourth part of this lecture describes work in our laboratory that is focused on identifying the metabolic pathways that...

Tuberculosis: A Persistent Threat to Global Health - Part 3: Phenotypic Heterogeneity and Antibiotic Tolerance (27:15)

submitted by: video_collector
The principal obstacle to successful treatment of tuberculosis is the lengthy duration of current regimens, which require administration of multiple drugs for 6-9 months. The requirement for prolonged therapy is attributed to sub-populations of bacillary "persisters" that are refractory to antimicrobials. The persisters are not drug-resistant in the conventional (heritable) sense and it is a mystery why they are spared whilst their genetically identical siblings are killed. The third part of...

Tuberculosis: A Persistent Threat to Global Health - Part 2: Tools for Tuberculosis Control: Not Just a Problem of Implementation (28:18)

submitted by: video_collector
Tuberculosis remains one of the most important causes of human disease and death despite the introduction of vaccination in 1921 and chemotherapy in 1952. Although these interventions are inexpensive and widely available their impact is limited. The effectiveness of vaccination is unclear; in clinical trials, the protection conferred by vaccination has been variable and generally poor. Although chemotherapy can be highly effective, multiple drugs must be administered for 6-9 months to provide...

Tuberculosis: A Persistent Threat to Global Health - Part 1: Tuberculosis: The Once and Future Plague (27:33)

submitted by: video_collector
Human population growth and urbanization have accelerated dramatically in recent centuries, providing unprecedented opportunities for microbes that use our bodies as vehicles for their own propagation and transmission. These conditions have led to the emergence of virulent new pathogens and the increased prevalence of "classic" scourges, such as Mycobacterium tuberculosis. This tenacious microbe is transmitted via infectious aerosols produced by individuals with pulmonary tuberculosis....

MacArthur Fellow 2008: Wafaa El-Sadr, physician

submitted by: video_collector
Wafaa El-Sadr is an Infectious Disease Physician introducing multi-pronged treatment strategies for some of the most pressing pandemics of our time – HIV/AIDS and TB – diseases that often afflict people with the least access to quality health care. MacArthur Fellowships offer the opportunity for Fellows to accelerate their current activities or take their work in new directions. The unusual level of independence afforded to Fellows underscores the spirit of freedom...

Return to Zambia MWV 17

submitted by: MicrobeWorld
The American Society for Microbiology is helping African nations foster a scientific community that is better able to address the current and future problems that threaten not only the local population, but the world at large. Like many African countries, Zambia and South Africa are deeply affected by HIV and tuberculosis, as well as a number of other infectious diseases. In March of 2008, ASM President Cliff Houston, Ph.D., traveled to Zambia and South Africa to gauge and assess the...

Adapting the DOTS framework for tuberculosis

submitted by: ahyde
In an interview about his forthcoming paper, Donald Enarson (from The International Union against Tuberculosis and Lung Disease in Paris) discusses how the DOTS paradigm could be adapted for controlling diseases such as diabetes in resource-poor countries.